Tag Archives: Continuous Glucose Monitoring

Patients with type 1 diabetes already face the daily burden of balancing insulin, food intake, exercise, and glucose monitoring. However, for some individuals, insulin becomes more than a treatment tool. It becomes a method for weight control. This dangerous behavior, commonly referred to as diabulimia, involves the intentional restriction or …

The management of diabetes during organ transplantation has become a growing clinical challenge. As transplant programs expand and survival rates improve, more patients are living with complex metabolic complications before and after surgery. One of the most important concerns is post-transplant hyperglycemia, which can affect patient outcomes at nearly every …

The conversation around DIY diabetes technology and patient-led insulin automation has changed dramatically over the past few years. What once existed on the margins of diabetes care is now gaining recognition from major medical organizations and healthcare providers. In fact, the 2026 American Diabetes Association (ADA) Standards of Care continue …

For many people living with diabetes, foot complications often begin quietly. A small pressure point, unnoticed inflammation, or minor skin breakdown can slowly develop into a serious ulcer. Unfortunately, traditional diabetic foot care has long been reactive. Clinicians typically intervene after visible wounds appear, when treatment becomes more difficult and …

The management of type 1 diabetes during pregnancy is entering a major turning point. For years, endocrinologists and maternal-fetal medicine specialists have worked within narrow therapeutic margins to reduce maternal and neonatal complications. However, new advances in automated insulin delivery technology for pregnancy are beginning to reshape glucose management in …

A bowl of oatmeal can keep one person’s glucose stable while sending another person’s blood sugar sharply upward. The meal is identical, yet the metabolic response is completely different. That reality is pushing many clinicians to reconsider one of the most established principles in diabetes nutrition: carb counting. The growing …

Automated insulin delivery for people with type 2 diabetes is entering a new phase. What once seemed reserved for highly specialized endocrinology clinics is now moving steadily into primary care offices across the country. Following the updated 2026 American Diabetes Association Standards of Care and recent FDA clearances, more adults …

A glucose alarm goes off during dinner. Another alert appears at 2 a.m. A smartphone app flashes warnings about rising blood sugar before the day even starts. Diabetes technology promises better control, yet for some patients, the nonstop stream of notifications and health data can feel mentally exhausting. Clinicians are …

Young adults diagnosed with type 2 diabetes early in life often face a more aggressive disease course than older adults. While metformin has long served as the standard first-line therapy, many clinicians are now reconsidering whether a “metformin-first and wait” strategy is enough for this higher-risk population. As research continues …

Cancer treatment is evolving rapidly, and with that progress comes a new challenge for clinicians managing glucose disorders. As immune checkpoint inhibitors (ICIs) and PI3K inhibitors become more widely used in oncology, therapy-related hyperglycemia is appearing more often in clinical practice. Many patients receiving cancer treatment now face unexpected glucose …